Search our website

CMV News and Insights

VBI Vaccines Announces Poster Presentation at the 7th International Congenital CMV Conference & 17th International CMV Workshop
Categories: Conferences, Cytomegalovirus ("CMV"), Glioblastoma ("GBM"), Press Releases
VBI Vaccines Provides Corporate Update, Outlook for 2019, and Year-End 2018 Financial Results
Categories: Cytomegalovirus ("CMV"), Glioblastoma ("GBM"), Hepatitis B, Press Releases, Sci-B-Vac®
VBI Vaccines Announces Phase 2 Clinical Study Design of its Prophylactic CMV Vaccine Candidate
Categories: Cytomegalovirus ("CMV"), Press Releases
VBI Vaccines’ Late-Breaker Cytomegalovirus Abstract Chosen for Oral Presentation at IDWeek 2018
Categories: Cytomegalovirus ("CMV"), Press Releases
VBI Vaccines Announces Formation of New Scientific and Clinical Advisory Boards
Categories: Cytomegalovirus ("CMV"), Glioblastoma ("GBM"), Press Releases, Sci-B-Vac®
VBI Vaccines Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine
Categories: Conferences, Cytomegalovirus ("CMV"), Press Releases
VBI Vaccines to Present at The World Vaccine Congress Europe 2017 in Barcelona
Categories: Cytomegalovirus ("CMV"), Press Releases, Zika
Developing Vaccine to Prevent Birth Defects from Cytomegalovirus
Categories: Cytomegalovirus ("CMV"), Media Mentions
VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine
Categories: Conferences, Cytomegalovirus ("CMV"), eVLP Platform, Press Releases
The State of U.S. CMV Legislation in 2017
Categories: Cytomegalovirus ("CMV")
Researchers Explore the Possible Link between CMV Infection, Obesity, and Metabolic Syndrome
Categories: Cytomegalovirus ("CMV")
VBI Vaccines Provides Update on its Congenital CMV Phase I Clinical Study
Categories: Cytomegalovirus ("CMV"), Press Releases
Researchers Assess Outcomes Following Passage of Utah CMV Legislation
Categories: Cytomegalovirus ("CMV")
Researchers Explore Possible Link Between CMV and Acute Lymphocytic Leukemia (“ALL”)
Categories: Cytomegalovirus ("CMV")
VBI Vaccines Completes Enrollment of Participants in the Phase I Clinical Trial of its Preventative Cytomegalovirus Vaccine Candidate
Categories: Cytomegalovirus ("CMV"), Press Releases
VBI Vaccines to Present at the Vaccine Congress
Categories: Conferences, Cytomegalovirus ("CMV"), Press Releases
VBI Vaccines to Continue Enrolling Participants in the Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate Following Successful Data Safety Monitoring Board Review
Categories: Cytomegalovirus ("CMV"), Press Releases
Researchers Explore Possible Link Between CMV and Alzheimer’s Disease
Categories: Cytomegalovirus ("CMV")
Researchers Explore the Mechanisms by Which CMV Infection May Impact Fetal Brain Development
Categories: Cytomegalovirus ("CMV")
VBI Vaccines Begins Enrolling Patients in a Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate
Categories: Cytomegalovirus ("CMV"), Press Releases
Browse by Year
Go top